53 Scoping review pediatric patient engagement Supplement 2 - (continued) First author Year Country N Disease group Age (min) Age (max) Used method* Setting Miller [175] 1995 United Kingdom 7 Multiple disease groups 12 19 1 Clinical care Miller [176] 2013 United States 20 Oncology 14 21 1 Research Mirlashari [177] 2021 Canada 5 Oncology 13 15 1 Clinical care Mitchell [178] 2014 United States 27 Degenerative disorders 13 22 1 Clinical care Morgan [179] 2018 United Kingdom 3 Oncology 13 18 2 Clinical care Morgan [180] 2009 United Kingdom 31 Oncology 13 24 7 Clinical care Morgan-Trimmer [181] 2016 United Kingdom 7 Diabetes 7 16 1 Clinical care Morrow [182] 2017 Australia 21 Multiple disease groups 7 17 1 Intervention development Moules [183] 2009 United Kingdom 9 Hospital admission 12 16 1 Clinical care Nahata [184] 2019 United States 14 Oncology 12 25 1 Research Needle [185] 2020 United States 10 Transplantation 14 27 5 Clinical care Nguyen [186] 2020 United States / Canada 32 Transplantation 12 24 2 Clinical care Nicholas [187] 2007 Canada 9 Multiple disease groups 4 17 1 Clinical care Nicholas [188] 2011 Canada 5 Multiple disease groups 4 17 1 Clinical care Nilsson [189] 2010 Sweden 39 Trauma 5 10 1 Clinical care Noyes [190] 2000 United Kingdom 18 Patients on a ventilator 6 18 1 Clinical care O’Callaghan [191] 2011 Australia 26 Oncology 4;6 8;2 1 Clinical care Omondi [192] 2013 United States 10 Sickle cell disease 12 16 2 Research Orr [193] 2020 Canada 25 Migraine 10 18 1 Clinical care Owen [194] 2013 United Kingdom 11 Obesity 5 18 1 Clinical care Padding [195] 2018 The Netherlands 41 Asthma 5 6 1 Clinical care Paquette [196] 2018 United States 20 Hospital admission 12 29 1 Research Parsons [197] 2018 United Kingdom 63 Juvenile Idiopathic Arthritis 11 24 2 Research Patterson [198] 2015 United States 29 Sickle cell disease 10 29 1 Research Pearce [199] 2016 United Kingdom 21 Oncology 15 24 1 Research 2
RkJQdWJsaXNoZXIy MTk4NDMw